Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis vaccines

C A Petruff1, A Bedford, F D Gordon

  • 1Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass 02215, USA.

Digestive Diseases (Basel, Switzerland)
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can Arthroplasty Stem Influence Outcome (CASINO): A Seven-Year Follow-Up of a Randomized Controlled Trial of Stem Length in Cemented Total Hip Arthroplasty.

The Journal of arthroplasty·2026
Same author

Two-stage Acetabular Impaction Bone Grafting: A Case Report.

Malaysian orthopaedic journal·2025
Same author

Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Performance Optimization of a Large Geometry High Resolution-Secondary Ion Mass Spectrometer (HR-SIMS) for High Precision Measurements of Oxygen Isotopic Composition (δ<sup>18</sup>O) and U-Pb Geochronology in Zircon.

Journal of mass spectrometry : JMS·2024
Same author

A propensity-score matched analysis of ventral-TAPP vs. laparoscopic IPOM for small and mid-sized ventral hernias. Comparison of perioperative data, surgical outcome and cost-effectiveness.

Hernia : the journal of hernias and abdominal wall surgery·2022
Same author

Correction to: Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients.

Archives of gynecology and obstetrics·2021
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Analysis of Helicobacter pylori resistance and its trends in Chongqing: A 10-year retrospective study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Viral hepatitis causes significant global illness and death. This review covers the development and current status of vaccines for hepatitis A, B, C, D, E, and G viruses.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Viral hepatitis represents a major global health burden, causing significant morbidity and mortality.
  • Six hepatotropic viruses (Hepatitis A, B, C, D, E, and G) have been identified.
  • Vaccination strategies are crucial for preventing viral hepatitis infections.

Purpose of the Study:

  • To review the development and current status of vaccines against hepatotropic viruses.
  • To highlight progress in vaccine research for viral hepatitis.
  • To provide an overview of existing and emerging hepatitis vaccines.

Main Methods:

  • Literature review of published studies on hepatitis virus vaccines.
  • Analysis of vaccine development pipelines for hepatitis A, B, C, D, E, and G.

Related Experiment Videos

  • Examination of regulatory approvals and clinical trial data for existing vaccines.

    • Main Results:

    • Two vaccines are currently FDA-approved in the US for Hepatitis A and Hepatitis B.
    • Significant research efforts are underway for vaccines targeting other hepatitis viruses.
    • Progress has been made in developing vaccines for Hepatitis C, D, E, and G.

    Conclusions:

    • Vaccines are a key strategy in controlling viral hepatitis worldwide.
    • Continued research and development are essential for a comprehensive hepatitis vaccine portfolio.
    • The review provides a snapshot of the evolving landscape of hepatitis virus vaccination.